Celebrating Dr. David Segal: A Leader in Science and a Champion for Angelman Syndrome Research
FAST congratulates longtime research partner Dr. David J. Segal on his appointment as Chair of Biochemistry and Molecular Medicine at UC Davis, a milestone for the AS research community.
FAST-Funded Project Introduces First Large Animal Model to Study Angelman Syndrome
FAST-funded researchers at Texas A&M created the first-ever pig model of Angelman syndrome using CRISPR, offering a new platform that more closely mirrors human brain biology.
FAST-funded researcher highlights the involvement of UBE3A in different neurodegenerative diseases
New research spotlights UBE3A as more than the gene behind Angelman syndrome—revealing how its role across brain cells could unlock insights for AS, autism, Alzheimer’s, and other neurological conditions.